Stephen J Magda

Title: The Innovative Contributions of Stephen J Magda

Introduction

Stephen J Magda is a notable inventor based in Hanover, Delaware. He has made significant contributions to the field of pharmacology through his innovative work on 1-phenyl-2-aminocarbonylindole compounds. With a total of 3 patents to his name, his research has the potential to impact medical treatments, particularly in antiarrhythmic applications.

Latest Patents

Magda's latest patents focus on novel 1-phenyl-2-aminocarbonylindole compounds. These compounds are characterized by a general formula that includes various substituents, allowing for a range of pharmacological properties. The compounds exhibit antiarrhythmic properties and can be formulated as free bases or acid addition salts. Additionally, pharmaceutical compositions containing these compounds and methods for their preparation are also described in his patents.

Career Highlights

Stephen J Magda is currently associated with Kali-Chemie Pharma GmbH, where he continues to advance his research in pharmacology. His work has led to the development of valuable intermediates for the production of his patented compounds. His contributions to the field are recognized for their potential therapeutic applications.

Collaborations

Magda has collaborated with esteemed colleagues such as Heinrich-Wilhelm Ohlendorf and Wilhelm Kaupmann. These collaborations have further enriched his research and development efforts in the pharmaceutical domain.

Conclusion

Stephen J Magda's innovative work in the field of pharmacology, particularly with 1-phenyl-2-aminocarbonylindole compounds, showcases his dedication to advancing medical science. His contributions are poised to make a significant impact on the treatment of arrhythmias and other related conditions.